-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NFuw90mK0coUGp9SG1n4PVtLrWE5vhaCcFUeHCYEUIof+O9Bt59/KHKcVi7fa8uS sKYd9d2XT+F2O8Al7WGHbQ== 0001072613-02-001200.txt : 20020808 0001072613-02-001200.hdr.sgml : 20020808 20020808172009 ACCESSION NUMBER: 0001072613-02-001200 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020808 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ASPECT MEDICAL SYSTEMS INC CENTRAL INDEX KEY: 0000886235 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 042985553 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-59557 FILM NUMBER: 02723386 BUSINESS ADDRESS: STREET 1: 141 NEEDHAM STREET CITY: NEWTON STATE: MA ZIP: 02464-1505 BUSINESS PHONE: (617) 559-7857 MAIL ADDRESS: STREET 1: 141 NEWTON STREET CITY: NEWTON STATE: MA ZIP: 02464-1505 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 BUSINESS PHONE: 5086508000 SC 13G 1 sc13g_11415.txt SCHEDULE 13G - ASPECT MEDICAL SYSTEMS, INC. ================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (RULE 13D-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13D-1(B)(C), AND (D) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13D-2(B) (AMENDMENT NO. __) 1/ ASPECT MEDICAL SYSTEMS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.01 PER SHARE (Title or Class of Securities) 045235108 (CUSIP Number) AUGUST 7, 2002 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |_| Rule 13d-1(b) |X| Rule 13d-1(c) |_| Rule 13d-1(d) 1/The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, SEE the Notes). ================================================================================ (Page 1 of 5 Pages) CUSIP No. 045235108 Page 2 of 5 - ---------- --------------------------------------------------------------------- 1 NAME OF REPORTING PERSON Boston Scientific Corporation S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS 04-2695240 - ---------- --------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) [_] (B) [_] - ---------- --------------------------------------------------------------------- 3 SEC USE ONLY - ---------- --------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware corporation - ---------- --------------------------------------------------------------------- 5 SOLE VOTING POWER 2,298,572 -------- ------------------------------------------ NUMBER OF SHARES 6 SHARED VOTING POWER 0 BENEFICIALLY OWNED BY -------- ------------------------------------------ EACH REPORTING 7 SOLE DISPOSITIVE POWER 2,298,572 PERSON WITH -------- ------------------------------------------ 8 SHARED DISPOSITIVE POWER 0 - ---------- --------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,298,572 - ---------- --------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] - ---------- --------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 11.9% - ---------- --------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* CO - ---------- --------------------------------------------------------------------- CUSIP No. 045235108 Page 3 of 5 ITEM 1(a). NAME OF ISSUER: Aspect Medical Systems, Inc. ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 141 Needham Street, Newton, MA 02462-1505 ITEM 2(a). NAME OF PERSON FILING: Boston Scientific Corporation ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: One Boston Scientific Place, Natick, MA 01760-1537 ITEM 2(c). CITIZENSHIP: Delaware, United States of America ITEM 2(d). TITLE OF CLASS OF SECURITIES: Common Stock, par value $0.01 per share, of Aspect Medical Systems, Inc. ITEM 2(e). CUSIP NUMBER: 045235108 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13D-1(B), OR 13D-2(B) OR (C), CHECK WHETHER THE PERSON FILING IS A: (a) |_| Broker or dealer registered under Section 15 of the Act. (b) |_| Bank as defined in Section 3(a)(6) of the Act. (c) |_| Insurance company as defined in Section 3(a)(19) of the Act. (d) |_| Investment company registered under Section 8 of the Investment Company Act. (e) |_| Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E). (f) |_| Employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F). (g) |_| Parent holding company, in accordance with Rule 13d-1(b) (1)(ii)(G). (h) |_| Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act. (i) |_| Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act. (j) |_| Group, in accordance with Rule 13d-1(b)(1)(ii)(J). If this statement is filed pursuant to Rule 13d-1(c), check this box. [X] CUSIP No. 045235108 Page 4 of 5 ITEM 4. OWNERSHIP: (a) Amount beneficially owned: 2,298,572 shares (b) Percent of class: 11.9% (c) Number of shares as to which such person has: (i) Sole power to vote or direct the vote: 2,298,572 shares (ii) Shared power to vote or direct the vote: Not applicable (iii) Sole power to dispose or to direct the disposition of: 2,298,572 shares (iv) Shared power to dispose or to direct the disposition of: Not applicable ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: Not applicable ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON: Not applicable ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY: Not applicable ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP: Not applicable ITEM 9. NOTICE OF DISSOLUTION OF GROUP: Not applicable ITEM 10. CERTIFICATION: By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. CUSIP No. 045235108 Page 5 of 5 SIGNATURE After reasonable inquiry and to the best of the knowledge and belief of the undersigned, the undersigned certifies that the information set forth in this statement is true, complete and correct. August 8, 2002 By: /s/ Lawrence J. Knopf --------------------------------------------- Name: Lawrence J. Knopf Title: Vice President and Assistant General Counsel -----END PRIVACY-ENHANCED MESSAGE-----